BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23618082)

  • 1. C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion.
    Kim JM; Kwon CH; Joh JW; Ko JS; Park JB; Lee JH; Kim SJ; Paik SW; Park CK
    World J Surg Oncol; 2013 Apr; 11():92. PubMed ID: 23618082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma.
    Nakanishi K; Sakamoto M; Yamasaki S; Todo S; Hirohashi S
    Cancer; 2005 Jan; 103(2):307-12. PubMed ID: 15593087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection.
    Eguchi S; Takatsuki M; Hidaka M; Soyama A; Tomonaga T; Muraoka I; Kanematsu T
    World J Surg; 2010 May; 34(5):1034-8. PubMed ID: 20127241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.
    Minagawa M; Makuuchi M; Takayama T; Kokudo N
    Ann Surg; 2003 Nov; 238(5):703-10. PubMed ID: 14578733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma.
    Kamiyama T; Nakanishi K; Yokoo H; Kamachi H; Tahara M; Kakisaka T; Tsuruga Y; Todo S; Taketomi A
    World J Surg Oncol; 2012 Jun; 10():107. PubMed ID: 22697061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of fibroblast growth factor 19 is associated with recurrence and poor prognosis of hepatocellular carcinoma.
    Hyeon J; Ahn S; Lee JJ; Song DH; Park CK
    Dig Dis Sci; 2013 Jul; 58(7):1916-22. PubMed ID: 23456506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of hepatocellular carcinoma accompanied by microscopic portal vein invasion.
    Shirabe K; Kajiyama K; Harimoto N; Masumoto H; Fukuya T; Ooya M; Maehara Y
    World J Gastroenterol; 2009 Jun; 15(21):2632-7. PubMed ID: 19496194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma invading portal venous system in cirrhosis: long-term results of percutaneous radiofrequency ablation of both the nodule and portal vein tumor thrombus. A case control study.
    Giorgio A; Calisti G; Montesarchio L; Scognamiglio U; Matteucci P; Coppola C; Scarano F; Amendola F; Giorgio V
    Anticancer Res; 2014 Nov; 34(11):6785-90. PubMed ID: 25368292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
    Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
    Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.
    Yang H; Xiong FX; Lin M; Yang Y; Nie X; Zhou RL
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):275-81. PubMed ID: 19690886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma.
    Makino Y; Yamanoi A; Kimoto T; El-Assal ON; Kohno H; Nagasue N
    Am J Gastroenterol; 2000 May; 95(5):1294-300. PubMed ID: 10811342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological predictors of poor survival and recurrence after curative resection in hepatocellular carcinoma without portal vein tumor thrombosis.
    Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
    Pathol Oncol Res; 2015 Jan; 21(1):131-8. PubMed ID: 24908141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic characteristics and surgical outcomes of hepatocellular carcinoma with portal vein tumor thrombosis.
    Chen JS; Wang Q; Chen XL; Huang XH; Liang LJ; Lei J; Huang JQ; Li DM; Cheng ZX
    J Surg Res; 2012 Jun; 175(2):243-50. PubMed ID: 21601221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting the prognosis of patients with hepatocellular carcinoma invading the portal vein--a retrospective analysis using 952 consecutive HCC patients.
    Koike Y; Nakagawa K; Shiratori Y; Shiina S; Imamura M; Sato S; Obi S; Teratani T; Hamamura K; Yoshida H; Omata M
    Hepatogastroenterology; 2003; 50(54):2035-9. PubMed ID: 14696460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term prognosis in hepatocellular carcinoma patients after hepatectomy.
    Zhou L; Liu C; Meng FD; Qu K; Tian F; Tai MH; Wei JC; Wang RT
    Asian Pac J Cancer Prev; 2012; 13(2):483-6. PubMed ID: 22524811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glasgow Prognostic Score as a useful prognostic factor after hepatectomy for hepatocellular carcinoma.
    Horino K; Beppu T; Kuroki H; Mima K; Okabe H; Nakahara O; Ikuta Y; Chikamoto A; Ishiko T; Takamori H; Baba H
    Int J Clin Oncol; 2013 Oct; 18(5):829-38. PubMed ID: 22821222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma.
    Hu S; Wu X; Zhou B; Xu Z; Qin J; Lu H; Lv L; Gao Y; Deng L; Yin J; Li G
    J Cancer Res Clin Oncol; 2014 Jun; 140(6):883-93. PubMed ID: 24647926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of GOLM1 correlates with prognosis in human hepatocellular carcinoma.
    Chen MH; Jan YH; Chang PM; Chuang YJ; Yeh YC; Lei HJ; Hsiao M; Huang SF; Huang CY; Chau GY
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S616-24. PubMed ID: 23838921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal venous invasion: the single most independent risk factor for immediate postoperative recurrence of hepatocellular carcinoma.
    Choi KK; Kim SH; Choi SB; Lim JH; Choi GH; Choi JS; Kim KS
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1646-51. PubMed ID: 21592228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.